Hydroxyurea glioma

Jun 20, 2007 · Background: We evaluated the combination of imatinib mesylate and hydroxyurea in recurrent/progressive low-grade gliomas (LGG) following the encouraging response of this combination demonstrated among adults with recurrent malignant glioma. METHODS: A total of 64 patients with recurrent/progressive low-grade glioma were enrolled in this sin-gle-center study that stratified patients into astrocytoma and oligodendroglioma cohorts

2024-03-29
    Rosuvastatin morgens oder abends einnehmen
  1. 2010)
  2. , Siklos): Initial dose: 20 mg/kg orally once a day
  3. 1979
  4. All patients received 500 mg of hydroxyurea twice a day
  5. numbness or tingling of the fingers or toes